Tianshui Zhongxing Bio-Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: CNE1000020B6
  • SHE: 002772
CNY
11.15
-0.03 (-0.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore

Dashboard

1

With a growth in Net Profit of 24.56%, the company declared Very Positive results in Mar 26

  • The company has declared positive results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 564.96 MM
  • NET SALES(HY) At CNY 1,224.95 MM has Grown at 23.56%
  • ROCE(HY) Highest at 12.87%
2

With ROE of 12.17%, it has a very attractive valuation with a 1.20 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

CNY 3,880 Million (Small Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.30%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

12.17%

stock-summary
Price to Book

1.07

Revenue and Profits:
Net Sales:
483 Million
(Quarterly Results - Jun 2026)
Net Profit:
28 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.37%
0%
-10.37%
6 Months
-42.08%
0%
-42.08%
1 Year
14.36%
0%
14.36%
2 Years
85.22%
0%
85.22%
3 Years
26.7%
0%
26.7%
4 Years
48.07%
0%
48.07%
5 Years
-0.18%
0%
-0.18%

Tianshui Zhongxing Bio-Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.05%
EBIT Growth (5y)
23.28%
EBIT to Interest (avg)
3.08
Debt to EBITDA (avg)
1.99
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.33
Tax Ratio
0.27%
Dividend Payout Ratio
50.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.80%
ROE (avg)
4.17%

Valuation key factors

Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.20
EV to EBIT
12.10
EV to EBITDA
7.63
EV to Capital Employed
1.15
EV to Sales
2.43
PEG Ratio
0.04
Dividend Yield
3.84%
ROCE (Latest)
9.51%
ROE (Latest)
12.17%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -19.70% vs -3.37% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -83.04% vs 24.85% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "483.40",
          "val2": "602.00",
          "chgp": "-19.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "100.10",
          "val2": "247.20",
          "chgp": "-59.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "19.00",
          "val2": "14.60",
          "chgp": "30.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "20.20",
          "val2": "-3.30",
          "chgp": "712.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "27.70",
          "val2": "163.30",
          "chgp": "-83.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "54.00%",
          "val2": "287.70%",
          "chgp": "-23.37%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.46% vs 0.20% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 164.30% vs -20.68% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,098.30",
          "val2": "1,934.70",
          "chgp": "8.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "583.70",
          "val2": "414.00",
          "chgp": "40.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.00",
          "val2": "77.10",
          "chgp": "-26.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.80",
          "val2": "15.30",
          "chgp": "-55.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "334.60",
          "val2": "126.60",
          "chgp": "164.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "156.50%",
          "val2": "65.80%",
          "chgp": "9.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
483.40
602.00
-19.70%
Operating Profit (PBDIT) excl Other Income
100.10
247.20
-59.51%
Interest
19.00
14.60
30.14%
Exceptional Items
20.20
-3.30
712.12%
Consolidate Net Profit
27.70
163.30
-83.04%
Operating Profit Margin (Excl OI)
54.00%
287.70%
-23.37%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -19.70% vs -3.37% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -83.04% vs 24.85% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
2,098.30
1,934.70
8.46%
Operating Profit (PBDIT) excl Other Income
583.70
414.00
40.99%
Interest
57.00
77.10
-26.07%
Exceptional Items
6.80
15.30
-55.56%
Consolidate Net Profit
334.60
126.60
164.30%
Operating Profit Margin (Excl OI)
156.50%
65.80%
9.07%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 8.46% vs 0.20% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 164.30% vs -20.68% in Dec 2024

stock-summaryCompany CV
About Tianshui Zhongxing Bio-Technology Co., Ltd. stock-summary
stock-summary
Tianshui Zhongxing Bio-Technology Co., Ltd.
FMCG
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading